Abstract
Background Millions of primary school students across the United States are about to return to in-person learning. Amidst circulation of the highly infectious Delta variant, there is danger that without the appropriate safety precautions, substantial amount of school-based spread of COVID-19 may occur.
Methods We used an extended Susceptible-Infected-Recovered computational model to estimate the number of new infections during 1 semester among a student population under different assumptions about mask usage, routine testing, and levels of incoming protection. Our analysis considers three levels of incoming protection (30%, 40%, or 50%; denoted as “low”, “mid”, or “high”). Universal mask usage decreases infectivity by 50%, and weekly testing may occur among 50% of the student population; positive tests prompt quarantine until recovery, with compliance contingent on symptom status.
Results Without masking and testing, more than 75% of susceptible students become get infected within three months in all settings. With masking, this values decreases to 50% for “low” incoming protection settings (“mid”=35%, “high”=24%). Testing half the masked population (“testing”) further drops infections to 22% (16%, 13%).
Conclusion Without interventions in place, the vast majority of susceptible students will become infected through the semester. Universal masking can reduce student infections by 26-78%, and biweekly testing along with masking reduces infections by another 50%. To prevent new infections in the community, limit school absences, and maintain in-person learning, interventions such as masking and testing must be implemented widely, especially among elementary school settings in which children are not yet eligible for the vaccine.
Competing Interest Statement
Dr. Ivy reported receiving grants from the CDC, CSTE, NCATS, and NC State University during the conduct of the study. Dr. Mayorga reported receiving grants from the NCATS/NIH, CSTE, CDC, and NC State University during the conduct of the study. Dr. Keskinocak reported receiving grants from CDC, CSTE, and Georgia Institute of Technology during the conduct of the study. Dr. Swann reported receiving grants from NCATS/NIH, CDC, CSTE, and NC State University during the conduct of the study. No other disclosures were reported.
Funding Statement
This research was supported by grant UL1TR002489 from the NCATS/NIH; Cooperative Agreement NU38OT000297 from the CSTE and the CDC; grant KL2TR002490 from the NCATS/NIH; The research also received partial support from the Georgia Institute of Technology and NC State University. The funders had no role in the design and conduct of the study, collection, management, analysis, and interpretation of the data, preparation, review, or approval of the manuscript, and the decision to submit the manuscript for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was exempted by the UNC Institutional Review Board (#20-2087).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
We have added to authors to the list of authors who also contributed to this manuscript
Data Availability
All data utilized for the development of this model is available upon request.
